Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Versus Intermittent Nebulization Therapy in Acute Asthma Exacerbation at Emergency Department
TCTR20250918001Phase 3Completed
- Sponsor
- Subcommittee on Research Grant Consideration and Promotion, Thammasat University
- Start
- Nov 2024
- Countries
- 1
01
Overview
Phase 3 trial in asthma (2 arms), sponsored by Subcommittee on Research Grant Consideration and Promotion, Thammasat University. Started Nov 2024; status: completed.
02
Conditions
asthma
Beyond the preview
Go deeper on TCTR20250918001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250918001.